
|Articles|December 15, 2002
The Growth Factor
New York-The pharmacologic use of growth factors already FDA approved and useful in treating recalcitrant diabetic leg ulcers shows promise as an off-label therapy for other wounds that heal slowly, Chris Arpey, M.D., associate director of dermatologic surgery, University of Iowa, said.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Derm Dispatch: What 'Free to Be Me' Means to Tori Spelling and Stella McDermott
3
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
4
Dermatology Conferences and Meetings Calendar: December 2025
5


















